Enterosgel paste 405 g

Storage

active substance: 100 g of paste contains 70 g of methylsilicic acid hydrogel;

excipients: purified water.

Medicinal form

Paste for oral use.

The main physical and chemical properties: a homogeneous paste-like mass of white color, odorless.

Pharmacotherapeutic group

Enterosorbents. ATX code A07V S.

Pharmacological properties

Pharmacodynamics.

Enterosgel is an inert silicon-organic compound. When used, it has a sorption effect. The drug effectively adsorbs medium-molecular toxic substances of exo- and endogenous origin, products of incomplete metabolism, incorporated radionuclides and naturally removes them from the body.

Enterosgel eliminates the manifestations of toxicosis, improves the function of intestines, liver, kidneys, normalizes blood and urine indicators.

Pharmacokinetics.

Covering the mucous membrane of the stomach and intestines, Enterosgel protects it from erosive processes, helps to increase local immunity.

Enterosgel is not absorbed from the intestines and does not undergo metabolic or chemical transformations.

Indication

As part of complex detoxification therapy for chronic renal failure; with toxic hepatitis, viral hepatitis A, B, liver cirrhosis and cholestasis of various etiologies; with enterocolitis, colitis, diarrhea, gastritis with reduced acidity, with alcohol and drug poisoning; with allergic and skin diseases (diatheses, neurodermatitis); with burn intoxication; purulent-septic and inflammatory processes accompanied by intoxication; toxicoses of pregnant women in the first half of pregnancy, in complex therapy of intestinal dysbacteriosis.

Contraindication

Acute intestinal obstruction.

Interaction with other medicinal products and other forms of interaction

The drug can reduce the effect of other drugs that are used together with it. Simultaneous use with drugs belonging to the class of bile acid sequestrants, such as cholestyramine, is not recommended due to the increased likelihood of constipation.

The drug should not be used together with silver drugs.

Features of use

Provided that the method of application is observed (Enterosgel and medicinal products are taken at an interval of 1.5-2 hours), the drug can be used in complex therapy with other medicinal and prophylactic agents, including prebiotics and probiotics (bifidum, lactobacilli), phytopreparations, adaptogens, immunomodulators.

Use during pregnancy or breastfeeding.

The drug can be used during pregnancy or breastfeeding. Use should be limited to pregnant women who are prone to constipation.

The ability to influence the speed of reaction when driving vehicles or other mechanisms.

Does not affect.

Method of application and dosage

Apply internally 3 times a day 1.5-2 hours before or 2 hours after meals or taking medications, drinking a sufficient amount of water.

For adults and children over 14 years of age, a single dose of the drug is 15 g (a tablespoon), a daily dose is 45 g.

For children from birth to 5 years: a single dose of the drug is 5 g (teaspoon), daily – 15 g; from 5 to 14 years: single dose – 10 g (dessert spoon), daily dose – 30 g.

The course of treatment is from 7 to 14 days.

With severe forms of the disease, a double single dose can be used for the first three days, and with a chronic course of the disease (chronic kidney failure), longer (up to 1 month) use of the drug is possible.

Children.

The drug can be used for children from birth. For children under 2 years of age, a single dose of the drug can be mixed with a small amount of water before use.

Overdose

Cases of overdose have not been described. In case of overdose, side effects may increase.

Side effects

When taking the drug, dyspeptic phenomena are possible. In the first days of taking the drug, constipation may develop. To prevent it for people prone to constipation, in the first two days of taking the drug, a cleansing enema at night or the use of laxatives (lactulose, sodium picosulfate) is recommended.

Expiration date

3 years.

Storage conditions

Store at a temperature of no more than 25 °C, do not allow freezing. After freezing, it loses its properties. After opening the package, store in the same conditions in a tightly closed container.

Keep out of the reach of children.

Packaging

405 g each in a container; 1 container in a cardboard box; 15 g in a bag; 15 or 30 bags in a cardboard box; 90 g or 225 g in a tube; 1 tube in a cardboard box.

Leave category

Without a prescription.

Producer

PJSC KREOMA-PHARM.

Address

Ukraine, Kyiv, str. Radishcheva, 3.